Listing analysis and research matching Diagnostics:
GE and Lilly ink cancer diagnostics linkup
In a sign of the accelerating convergence between treatments and diagnostics GE and Eli Lilly have announced a collaboration to develop in vitro diagnostic assays that may help predict cancer treatment response to targeted therapies.
